New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Your daily dose of insights
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
The health secretary, Vice President JD Vance and other top officials addressed a conference sponsored by corporations, including A.I. companies and others with business before the government.
Patients and doctors are eager for a noninvasive way to diagnose the disease, and several start-ups are offering new options. Here’s what to know about them.
The 30-plant goal has crept into the lexicon of the online wellness world. We asked experts where it came from, and whether it’s legitimate.
Your pet has been your bed partner for years. Now, your sleep and relationship are suffering. Here’s what to do.
A new study identified more than 1 million people taking weight-loss drugs without any apparent medical reason to do so.
They’re marketed like nicotine or estrogen patches. But it’s not clear whether vitamins or herbal extracts can be absorbed through the skin.
Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.
Veterans under 30 will have to sign forms before being given antidepressants. Medical groups fear the moves may stigmatize mental health treatment.
Federal officials are drafting an executive order that would place grants under review by an outside panel, the latest effort to redirect billions of dollars in research spending.